These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19102508)

  • 1. [Cyclooxygenase-2 and cyclooxygenase-2 inhibitors in prostate cancer].
    Xu S; Gao JP; Zhou WQ
    Zhonghua Nan Ke Xue; 2008 Nov; 14(11):1031-4. PubMed ID: 19102508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2: a therapeutic target for prostate cancer.
    Pruthi RS; Wallen EM
    Clin Genitourin Cancer; 2005 Dec; 4(3):203-11. PubMed ID: 16425990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
    Moreno J; Krishnan AV; Peehl DM; Feldman D
    Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
    Harris RE
    Inflammopharmacology; 2009 Apr; 17(2):55-67. PubMed ID: 19340409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors induce colon cancer cell apoptosis Via PPARdelta --> 14-3-3epsilon pathway.
    Wu KK; Liou JY
    Methods Mol Biol; 2009; 512():295-307. PubMed ID: 19347284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells.
    Lee KS; Lee HJ; Ahn KS; Kim SH; Nam D; Kim DK; Choi DY; Ahn KS; Lu J; Kim SH
    Cancer Lett; 2009 Jul; 280(1):93-100. PubMed ID: 19289254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of therapeutic approaches to gastric cancer.
    Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
    J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple roles of cyclooxygenase-2 in endometrial cancer.
    Ohno S; Ohno Y; Suzuki N; Inagawa H; Kohchi C; Soma G; Inoue M
    Anticancer Res; 2005; 25(6A):3679-87. PubMed ID: 16302726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 and tumor biology.
    Kanaoka S; Takai T; Yoshida K
    Adv Clin Chem; 2007; 43():59-78. PubMed ID: 17249380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
    Sooriakumaran P; Coley HM; Fox SB; Macanas-Pirard P; Lovell DP; Henderson A; Eden CG; Miller PD; Langley SE; Laing RW
    Anticancer Res; 2009 May; 29(5):1483-8. PubMed ID: 19443354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 in cancer and angiogenesis.
    Sahin M; Sahin E; Gümüslü S
    Angiology; 2009; 60(2):242-53. PubMed ID: 18505747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
    Guo JY; Li CY; Ruan YP; Sun M; Qi XL; Zhao BS; Luo F
    Eur J Pharmacol; 2009 Jun; 612(1-3):54-60. PubMed ID: 19356723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.
    Maussang D; Langemeijer E; Fitzsimons CP; Stigter-van Walsum M; Dijkman R; Borg MK; Slinger E; Schreiber A; Michel D; Tensen CP; van Dongen GA; Leurs R; Smit MJ
    Cancer Res; 2009 Apr; 69(7):2861-9. PubMed ID: 19318580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
    Takeda S; Yamamoto I; Watanabe K
    Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for new COX-2 inhibitors: a review of 2002 - 2008 patents.
    Ramalho TC; Rocha M; da Cunha EF; Freitas MP
    Expert Opin Ther Pat; 2009 Sep; 19(9):1193-228. PubMed ID: 19563267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
    Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib.
    Urdaneta A; Siso A; Urdaneta B; Cardenas R; Quintero L; Avila R; Suarez-Roca H
    Brain Res Bull; 2009 Aug; 80(1-2):56-61. PubMed ID: 19463915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
    Wang W; Bergh A; Damber JE
    APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
    Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
    Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.